Webinar | Investing in Europe: Q&A on Executing and Financing Deals Post-Pandemic – Part I

Oct 2020

Lincoln International hosted a virtual panel on October 22, 2020 to discuss considerations and opportunities for investors and businesses alike in the new deal landscape. Professionals from the firm’s European Debt Advisory and M&A teams delve into themes, including lenders & financing, key M&A markets and sector trends, as well as changes to deal structure in a post-pandemic environment.

Lincoln is joined by Adrian Balcombe, Managing Director at Alvarez and Marsal for this webinar.

Discussion topics include:

Post-pandemic trends in lending & financing

  • Specific sector focus
  • Preparing for a potential GDP-led recession
  • Trends & tips in financing post-COVID

Looking ahead – opportunities for M&A

  • Convergence of tech into other sectors (i.e. healthcare, industrials and business services) to create opportunity through digital transformation
    ​ ​ ​ ​ ​ – ​ How will PE funds look to deploy capital?
    ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ – ​ Industry 4.0 / financial technology / unified communications
  • Sustainable investing
  • Will there be key focus markets for investors in Europe?

Successfully executing M&A deals – adjustments & KPI’s

  • How to navigate new levels of valuations in healthcare, technology & e-commerce
    ​ ​ ​ ​ ​ – ​ Structural elements (earn-outs and vendor loans)
    ​ ​ ​ ​ ​ – ​ Will different transaction structures impact activity?
    ​ ​ ​ ​ ​ – ​ Finance providers flexing their structures to meet the M&A requirements (earn-out facilities / DDTL possibly bringing recurring revenue financing, etc.)
  • Re-energising processes previously on hold
    ​ ​ ​ ​ ​ – ​ Industry 4.0 / financial technology / unified communications

 
Please complete the form below to request access to this recording



Summary

Contributors

Meet our Senior Team in Europe

Related Perspectives

CNBC | UK, EU Private Companies Remain Strong

Originally aired on CNBC on November 22, 2022. Richard Olson, Managing Director in Lincoln’s Valuations & Opinions Group, explains why private companies are experiencing resiliency.

In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners

Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More

The Hidden Gem in European Pet Food: European Investors Spot New Opportunity in Raw & Gently Cooked Pet Food

European investors are capitalizing on the fastest growing segment of the European pet food category, powered by pet owners’ ongoing desire for higher quality and natural food options for their… Read More

RealDeals | RoundTable: Deal Origination and Transactions Today

Originally published by Real Deals on November 3, 2022. Click here to read full article. What changes are we seeing in the market as a result of the current backdrop? There… Read More